| Document Date: 2015-07-19 14:34:53
Open Document File Size: 48,65 KBShare Result on Facebook
City Washington / DC / / Company Patient.co.uk / Go A. S. / Daiichi Sankyo Group / Daiichi Sankyo / Press Release Daiichi Sankyo Europe GmbH / / Continent Europe / / Country Germany / France / Japan / United States / Brazil / United Kingdom / Spain / / / / IndustryTerm stroke prevention / healthcare professionals / complexities surrounding management / marketed pharmaceuticals / Care of Stroke / treatment for stroke / pharmaceutical products / value chain / therapy for stroke / / MedicalCondition arrhythmia / Strokes / Stroke Associated With Atrial Fibrillation / hypertension / heart rhythm disorders / disease / epidemic / stroke / Advanced Illness / cardiac arrhythmia / cardiovascular-metabolic diseases / Non-Valvular Atrial Fibrillation / appropriate stroke / hemorrhagic stroke / thrombotic disorders / A. S. et al. Heart Disease / Atrial Fibrillation / dyslipidemia and bacterial infections / non-AF related strokes / / Organization Task Force for the Management / World Health Organization / Heart Rhythm Society Barcelona / European Society of Cardiology / European Union / / Person Wolfhard Erdlenbruch / Hugh Calkins / Harris Poll / / / Position Director Medical Affairs / Executive Director / President / physician / international leader / / URL www.tcpdf.org / www.daiichisankyo.com / www.myAFib.org / www.daiichi-sankyo.eu / www.patient.co.uk/pdf/4198.pdf / /
SocialTag |
Press Release Daiichi Sankyo Europe GmbH ZielstattstrasseMunich · Germany Phone +